Department of Health (2006) Immunisation against infectious disease – the green book. London: Department of Health.
Department of Health (2002) Getting ahead of the curve: a strategy for combating infectious diseases (including other aspects of health protection). London: Department of Health.
Edmunds WJ, Medley GF, Nokes DJ et al. (1993) The influence of age on the development of the hepatitis B carrier state. Proceedings B 253: 197–201.
Foster GR, Fried MW, Hadziyannis SJ et al. (2007) Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin. Scandinavian Journal of Gastroenterology 42 (2): 247–55.
Hahné S, Ramsay M, Balogun K et al. (2004) Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995–2000: implications for immunisation policy. Journal of Clinical Virology 29: 211–20.
Harris RJ, Ramsay M, Hope V et al. (2012a) Hepatitis C prevalence in England remains low and varies by ethnicity: an updated evidence synthesis. European Journal of Public Health 22 (2): 187–92.
Harris RJ, Hope V, Marongiou A (2012b) Spatial mapping of hepatitis C prevalence in recent injecting drug users in contact with services. Epidemiology and Infection 140 (6): 1054–63.
Health Protection Agency (2012) Acute hepatitis B (England): annual report for 2011 Infections report, 6 (34). London: Health Protection Agency Centre for Infections.
Health Protection Agency (2011a) Health protection report weekly report 4 (34). London: Health Protection Agency Centre for Infections.
Health Protection Agency (2011b) Hepatitis C in the UK 2011. London: Health Protection Agency Centre for Infections.
Health Protection Agency (2011c) Shooting up: Infections among people who inject drugs in the UK 2010. An update: November 2011. London: Health Protection Agency.
Health Protection Agency (2011d) Sentinel surveillance of hepatitis testing in England. Hepatitis B and D 2010 report. Analysis of testing between 2007 and 2010. London: Health Protection.
Hickman M, McDonald T, Judd A et al. (2008) Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomised controlled trial. Journal of Viral Hepatitis 15: 250–4.
Hope V, Ncube F, Hickman M et al. (2007) Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements? Journal of Viral Hepatitis 14 (9): 653–60.
Judd A, Hickman M, Hope V et al. (2007) Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales? Journal of Viral Hepatitis 14 (8): 584–9.
NHS Education for Scotland (2010) Hepatitis C workforce education development: an outline of requirements. Edinburgh: NHS Education for Scotland.
Perz JF, Armstrong GL, Farrington LA, et al. (2006) The contribution of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology 45: 529–38.
Scottish Executive (2008) Hepatitis C Action Plan for Scotland: phase II: May 2008 – March 2011. Edinburgh: Scottish Executive.
Scottish Executive (2006) Hepatitis C Action Plan for Scotland – phase I: September 2006 – August 2008. Edinburgh: Scottish Executive.